Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group

Por Kirby, Sarah, Gertler, Stan Z., Mason, Warren, Watling, Christopher, Forsyth, Peter, Aniagolu, Jacinta, Stagg, Robert, Wright, Matthew, Powers, Jean, Eisenhauer, Elizabeth A.
Publicado em 2005

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Por Jaeckle, K A, Phuphanich, S, Bent, M J van den, Aiken, R, Batchelor, T, Campbell, T, Fulton, D, Gilbert, M, Heros, D, Rogers, L, O'Day, S J, Akerley, W, Allen, J, Baidas, S, Gertler, S Z, Greenberg, H S, LaFollette, S, Lesser, G, Mason, W, Recht, L, Wong, E, Chamberlain, M C, Cohn, A, Glantz, M J, Gutheil, J C, Maria, B, Moots, P, New, P, Russell, C, Shapiro, W, Swinnen, L, Howell, S B
Publicado em 2001

ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK...

Por Bell, Erica H, Zhang, Peixin, Shaw, Edward G, Buckner, Jan C, Barger, Geoffrey R, Coons, Stephen W, Bullard, Dennis E, Mehta, Minesh P, Gilbert, Mark R, Brown, Paul D, Stelzer, Keith J, Fleming, Jessica, McElroy, Joseph P, Timmers, Cynthia D, Becker, Aline Paixao, Salavaggione, Andrea L, Liu, Ziyan, Aldape, Ken, Brachman, David G, Gertler, Stanley Z, Murtha, Albert D, Schultz, Christopher J, Johnson, David, Shu, Hui-Kuo, Chakravarti, Arnab
Publicado no Neuro Oncol (2017)